that didnt take long, page-3

BTA will move up in price when Relenza restocking restarts.

IMO restocking is being managed by GSK to recommence until after July 2011 so as GSK does not have to book any June quarter royalty payments for full year 30/6/2011 and which will be payable to BTA in July 2011

Past history shows the September quarter is the active one.

Remember GSK has 190 doses on the shelf teady to roll.

That is around $4 billion in sales or $280 million in royalties.

The stockpile at GSK will not be wasted

The clock is ticking in our favour.